GOSSELIES, Belgium–(BUSINESS WIRE)– Regulatory News: BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair, fracture prevention and spinal fusion, today reports its full year results for the year ending 31 December 2015, prepared in accordance with IFRS as […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone